CDK4/6 Inhibitors in Melanoma: A Comprehensive Review

Historically, metastatic melanoma was considered a highly lethal disease. However, recent advances in drug development have allowed a significative improvement in prognosis. In particular, BRAF/MEK inhibitors and anti-PD1 antibodies have completely revolutionized the management of this disease. None...

Descripción completa

Detalles Bibliográficos
Autores principales: Garutti, Mattia, Targato, Giada, Buriolla, Silvia, Palmero, Lorenza, Minisini, Alessandro Marco, Puglisi, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227121/
https://www.ncbi.nlm.nih.gov/pubmed/34071228
http://dx.doi.org/10.3390/cells10061334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227121/
https://www.ncbi.nlm.nih.gov/pubmed/34071228
http://dx.doi.org/10.3390/cells10061334

Ejemplares similares